Evidence map›Paper›PMID 41754872›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Comprehensive Investigation of a Novel Schiff Base: Synthesis, Anticancer Efficacy, Gene Expression Profiling, and Computational Analyses.

Tugba Agbektas, Özhan Pazarcı, Ayca Tas, Alakbar Huseynzada, Ruslan Guliyev, Ulviyya Hasanova, Emre Can Buluz, Savas Kaya, Alejandro Morales-Bayuelo, Yavuz Silig

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tugba AgbektasDepartment of Food Processing Technologies Services, Yıldızeli Vocational School, Sivas Cumhuriyet University, Sivas 13001, Türkiye.
Özhan PazarcıDepartment of Orthopedics and Traumatology, Adana City Training and Research Hospital, Adana 01000, Türkiye.
Ayca TasDepartment of Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye.ORCID 0000-0002-7132-1325
Alakbar HuseynzadaICRL, Baku State University, Z. Khalilov 23, Baku AZ1148, Azerbaijan.ORCID 0000-0002-6342-4260
Ruslan GuliyevGPOGC SRI, Azerbaijan State Oil and Industry University, Baku AZ1148, Azerbaijan.
Ulviyya HasanovaICESCO Biomedical Materials Department, Baku State University, Z. Khalilov 33, Baku AZ1148, Azerbaijan.
Emre Can BuluzDepartment of Biotechnology, Institute of Science, Ege University, Izmir 35100, Türkiye.
Savas KayaDepartment of Chemistry, Faculty of Science, Sivas Cumhuriyet University, Sivas 58140, Türkiye.ORCID 0000-0002-0765-9751
Alejandro Morales-BayueloGrupo Genoma, Escuela de Medicina, Universidad del Sinú, Cartagena 130001, Colombia.ORCID 0000-0001-9159-5289
Yavuz SiligDepartment of Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1)

Indexed as

anticancer drugDFTgene expressionmagnetism analysesmolecular dockingSAOS-2

Identifiers

PMID41754872
PMCPMC12943978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.